1. Home
  2. XENE vs FA Comparison

XENE vs FA Comparison

Compare XENE & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc.

SELL

Current Price

$38.80

Market Cap

3.7B

Sector

Health Care

ML Signal

SELL

Logo First Advantage Corporation

FA

First Advantage Corporation

SELL

Current Price

$21.16

Market Cap

3.7B

ML Signal

SELL

Company Overview

Basic Information
Metric
XENE
FA
Founded
1996
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
XENE
FA
Price
$38.80
$21.16
Analyst Decision
Strong Buy
Buy
Analyst Count
18
10
Target Price
★ $71.56
$27.75
AVG Volume (30 Days)
1.2M
★ 2.1M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 72.97
EPS
N/A
★ 0.23
Revenue
$311,000.00
★ $1,574,389,000.00
Revenue This Year
N/A
$10.54
Revenue Next Year
$1,985.11
$7.72
P/E Ratio
★ N/A
$93.15
Revenue Growth
N/A
★ 83.02
52 Week Low
$33.38
$8.82
52 Week High
$72.66
$25.15

Technical Indicators

Market Signals
Indicator
XENE
FA
Relative Strength Index (RSI) 47.51 49.32
Support Level $33.38 $19.47
Resistance Level $39.92 $21.66
Average True Range (ATR) 1.44 0.85
MACD 0.45 -0.16
Stochastic Oscillator 39.58 7.90

Price Performance

Historical Comparison
XENE
FA

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: